Crossmark

Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors

Published Online: 2017-09-25

Published Print: 2017-12

Authors

Shen, Lin

Sun, Yan

Xu, Jian-Ming

Linn, Carlos https://orcid.org/0000-0001-7470-3882
Wang, Qiao

Yang, Li-Qiang

Qin, Shu-Kui
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00793871 at ClinicalTrials.gov

Documents that mention this clinical trial

Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
https://doi.org/10.1007/s40487-017-0052-4
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2017-09-25

Version of Record valid from 2017-09-25
More Information

Article History

Received: 25 April 2017

First Online: 25 September 2017

Document is current